New Key Statistics Module, Z-Score and F-Score
NAS:VRTX Key Ratios
Market Cap $ M | 110,804.25 |
Enterprise Value $ M | 100,654.93 |
P/E(ttm) | 27.86 |
PE Ratio without NRI | 25.36 |
Forward PE Ratio | 26.51 |
Price/Book | 5.98 |
Price/Sales | 10.99 |
Price/Free Cash Flow | 32.19 |
Price/Owner Earnings | 35.56 |
Payout Ratio % | -- |
Revenue (TTM) $ M | 10,185.00 |
EPS (TTM) $ | 15.41 |
Beneish M-Score | -2.06 |
10-y EBITDA Growth Rate % | -- |
5-y EBITDA Growth Rate % | 41.40 |
y-y EBITDA Growth Rate % | 14.10 |
EV-to-EBIT | 20.92 |
EV-to-EBITDA | 20.10 |
PEG | 0.61 |
Shares Outstanding M | 258.05 |
Net Margin (%) | 39.46 |
Operating Margin % | 43.20 |
Pre-tax Margin (%) | 46.81 |
Quick Ratio | 3.29 |
Current Ratio | 3.50 |
ROA % (ttm) | 18.66 |
ROE % (ttm) | 24.35 |
ROIC % (ttm) | 45.25 |
Dividend Yield % | -- |
Altman Z-Score | 14.58 |
VRTX Number of Guru Trades
VRTX Volume of Guru Trades
Gurus Latest Trades with NAS:VRTX
You need a Premium membership or above to view this section.
Take a 7-Day Free Trial
No Available Data
NAS:VRTX is held by these investors
Total 6
Vertex Pharmaceuticals Inc Insider Transactions
No Available Data
News about NAS:VRTX
Total 0- 1